The funding will cover the development of a man-made osteochondral scaffold for large defect repairs.
Osteochondral injuries are repetitive trauma that occur within a joint such as the knee or elbow.
It is partnering with University College London and Oxford MEStar, a firm specialising in translational and regenerative medicine.
“Our relationship with UCL has already led to the licensing of novel collagen material from the laboratories of professor Brown,” said Collagen Solutions chief executive Stewart White.
“This new grant widens our collaboration with the university and will lead to the development of another collagen based, high value added product which fits in with our strategy of releasing the embedded functionality of our medical grade collagen through the development and commercialisation of high value added novel products."
The size and terms of the grant weren’t revealed.
Collagen Solutions develops and manufactures medical grade collagen components for use in regenerative medicine and medical devices diagnostics.